Catechin
Research stageAlso known as (+)-Cyanidan-3-ol, (+)-Cyanidanol, (2R,3S)-(+)-Catechin, (2R,3S)-catechin+8 more
(+)-Cyanidan-3-ol, (+)-Cyanidanol, (2R,3S)-(+)-Catechin, (2R,3S)-catechin, CIANIDANOL, Catechuic acid, Cianidanolum, D-(+)-Catechin, D-Catechol, d-Catechin, (+)-Catechol, (+)-catechin.
Recent clinical, regulatory, research and industry developments relating to this drug.
Health Functions and Related Molecular Mechanisms of Tea Components: An Update Review.
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Major research themes5
Journals, researchers & institutions
- International journal of molecular sciences1
- Molecules (Basel, Switzerland)1
- Nature communications1
- PloS one1
- Atanasov AG1
- Bian Z1
- Cannataro R1
- Caroleo MC1
- Chen T1
- Cione E1
- Corke H1
- Feng YB1
- Chinese Medicine Clinical Study Center1
- College of Veterinary Medicine1
- Functional Metabolomic and Gut Microbiome Laboratory1
- Guangdong Provincial Key Laboratory of Food1
- Institute of Urban Agriculture1
- School of Agriculture and Biology1
Related drugs
Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).
Studied across 3 of the same disease areas as Catechin in the shared literature.
Studied across 2 of the same disease areas as Catechin in the shared literature.
Studied across 2 of the same disease areas as Catechin in the shared literature.
- RxNorm (U.S. National Library of Medicine) — drug identity
- ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
- Europe PMC — research literature